Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Neuronetics, Inc. commercial stage medical technology company. The company is headquartered in Malvern, Pennsylvania and currently employs 191 full-time employees. The firm is focused on the design and development of medical devices to treat psychiatric disorders. The Company’s principal product is NeuroStar Advanced Therapy System. The company is a non-invasive treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed magnetic field to induce electrical pulses for stimulating certain areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorders. The firm offers its therapy systems to psychiatrist offices in the United States.
Website: neurostar.com



Growth: Good revenue growth rate 94.7%, there is acceleration compared to average historical growth rates 33.5%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -26.4%. On average the margin is improving steadily. Gross margin is high, +45.9%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.05 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -27.6% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 262.5% higher than minimum and 62.7% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.8x by EV / Sales multiple , the company can be 70.4% undervalued

Key Financials (Download financials)

Ticker: STIM
Share price, USD:  (0.0%)2.21
year average price 3.22  


year start price 3.15 2025-02-09

max close price 5.42 2025-03-05

min close price 1.27 2025-11-24

current price 2.21 2026-02-08
Common stocks: 67 309 000

Dividend Yield:  0.0%
EV / Sales: 1.7x
Margin (EBITDA LTM / Revenue): -26.4%
Fundamental value created in LTM:
Market Cap ($m): 149
Net Debt ($m): 66
EV (Enterprise Value): 215
Price to Book: 5.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-11-04zacks.com

Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates

2025-11-04globenewswire.com

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

2025-09-17globenewswire.com

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

2025-08-06globenewswire.com

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2025-08-05seekingalpha.com

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

2025-07-30globenewswire.com

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

2025-06-19globenewswire.com

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2025-06-10globenewswire.com

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

2025-05-06globenewswire.com

Neuronetics Reports First Quarter 2025 Financial and Operating Results

2025-03-29seekingalpha.com

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-04 2025-08-05 2024-11-12 2024-08-12 2024-05-07 2023-11-07 2023-08-08 2023-05-15 2022-11-08
acceptedDate 2025-11-04 07:31:53 2025-08-05 07:31:19 2025-03-27 16:36:09 2024-11-12 07:31:12 2024-08-12 07:30:58 2024-05-07 16:31:07 2024-03-07 21:44:57 2023-11-07 16:30:33 2023-08-08 16:31:51 2023-05-15 16:31:15 2023-03-07 16:39:58 2022-11-08 16:31:02 2022-03-08 16:31:12 2021-03-02 17:06:25
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 37M 38M 75M 19M 16M 17M 71M 18M 18M 16M 65M 16M 55M 49M
costOfRevenue 20M 20M 21M 5M 4M 5M 20M 6M 5M 4M 15M 4M 12M 12M
grossProfit 17M 18M 54M 14M 12M 13M 52M 12M 13M 11M 50M 13M 44M 38M
grossProfitRatio 0.459 0.466 0.756 0.74 0.719 0.658 0.725 0.733 0.784
researchAndDevelopmentExpenses 2M 2M 13M 2M 2M 2M 10M 2M 2M 3M 9M 2M 8M 9M
generalAndAdministrativeExpenses 11M 12M 30M 7M 6M 6M 25M 6M 6M 7M 26M 6M 26M 18M
sellingAndMarketingExpenses 12M 12M 46M 12M 12M 12M 47M 12M 12M 12M 50M 12M 38M 33M
sellingGeneralAndAdministrativeExpenses 23M 24M 76M 19M 18M 17M 73M 18M 18M 19M 75M 18M 63M 51M
otherExpenses 0 0 0 0 0 812 000 0 664 000 4M 640 000 0 0 0 0
operatingExpenses 24M 26M 89M 22M 21M 19M 82M 21M 20M 21M 85M 20M 71M 60M
costAndExpenses 45M 46M 109M 26M 25M 24M 102M 27M 25M 25M 100M 24M 83M 72M
interestIncome 0 0 0 0 0 0 24 000 520 000 452 000 0 0 0 0 0
interestExpense 2M 2M 7M 2M 2M 2M 5M 1M 1M 1M 4M 1M 3M 5M
depreciationAndAmortization 886 000 901 000 2M 512 000 555 000 560 000 2M 499 000 488 000 1M 2M 1M 1M 941 000
ebitda -6M -7M -34M -8M -7M -6M -23M -8M -3M -9M -32M -6M -27M -26M
ebitdaratio -0.173 -0.188 -0.417 -0.444 -0.362 -0.431 -0.186 -0.563 -0.373
operatingIncome -7M -8M -35M -8M -9M -7M -31M -9M -7M -10M -35M -7M -28M -22M
operatingIncomeRatio -0.196 -0.211 -0.417 -0.517 -0.394 -0.496 -0.417 -0.638 -0.452
totalOtherIncomeExpensesNet -2M -2M -9M -6M -1M -1M 365 000 664 000 4M -613 000 -2M -155 000 -4M -5M
incomeBeforeTax -9M -10M -44M -13M -10M -8M -30M -9M -5M -11M -37M -8M -31M -27M
incomeBeforeTaxRatio -0.252 -0.259 -0.72 -0.598 -0.452 -0.525 -0.278 -0.677 -0.461
incomeTaxExpense 0 0 -14 000 0 0 516 724 -24 000 2M 5M 613 000 0 155 000 0 0
netIncome -9M -10M -44M -13M -10M -8M -30M -9M -5M -11M -37M -8M -31M -27M
netIncomeRatio -0.243 -0.266 -0.72 -0.598 -0.452 -0.525 -0.278 -0.716 -0.471
eps -0.13 -0.15 -1.38 -0.44 -0.33 -0.27 -1.05 -0.33 -0.17 -0.4 -1.38 -0.29 -1.22 -1.46
epsdiluted -0.13 -0.15 -0.44 -0.33 -0.27 -0.33 -0.17 -0.4 -0.29
weightedAverageShsOut 67M 66M 32M 30M 30M 29M 29M 29M 29M 28M 27M 27M 25M 19M
weightedAverageShsOutDil 67M 66M 32M 30M 30M 29M 29M 29M 29M 28M 27M 27M 25M 19M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-27 2024-03-08 2023-03-07 2022-03-08 2021-03-02
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -7M -5M -4M -3M -5M
ebit -36M -25M -34M -28M -27M
nonOperatingIncomeExcludingInterest 2M -6M -2M 310 000 5M
netIncomeFromContinuingOperations -44M -30M -37M -31M -27M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 -24 000 49 000 -19 000 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -44M -30M -37M -31M -27M
epsDiluted -1.38 -1.05 -1.38 -1.22 -1.46

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-04 2025-08-05 2024-11-12 2024-08-12 2024-05-07 2023-11-07 2023-08-08 2023-05-15 2022-11-08
acceptedDate 2025-11-04 07:31:53 2025-08-05 07:31:19 2025-03-27 16:36:09 2024-11-12 07:31:12 2024-08-12 07:30:58 2024-05-07 16:31:07 2024-03-07 21:44:57 2023-11-07 16:30:33 2023-08-08 16:31:51 2023-05-15 16:31:15 2023-03-07 16:39:58 2022-11-08 16:31:02 2022-03-08 16:31:12 2021-03-02 17:06:25
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 34M 17M 19M 21M 43M 48M 60M 36M 46M 55M 70M 74M 94M 49M
shortTermInvestments 175 000 176 000 206 000 572 000 685 000 816 000 905 000 968 000 1M 1M 2M 2M 2M 2M
cashAndShortTermInvestments 35M 18M 20M 21M 43M 49M 61M 37M 47M 57M 72M 76M 96M 51M
netReceivables 19M 27M 24M 19M 20M 20M 18M 17M 15M 11M 14M 12M 8M 7M
inventory 4M 5M 4M 5M 6M 7M 8M 10M 9M 9M 9M 9M 7M 4M
otherCurrentAssets 7M 7M 7M 8M 7M 7M 5M 5M 5M 2M 2M 5M 3M 2M
totalCurrentAssets 65M 56M 58M 53M 76M 82M 94M 71M 78M 81M 99M 101M 115M 65M
propertyPlantEquipmentNet 29M 30M 33M 4M 4M 4M 5M 5M 5M 5M 5M 6M 5M 4M
goodwill 23M 19M 19M 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 19M 19M 20M 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 42M 38M 38M 0 0 0 0 0 0 0 0 0 0 0
longTermInvestments 315 000 103 000 86 000 140 000 3M 4M 661 000 700 000 859 000 989 000 1M 2M 2M 2M
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 10M 11M 11M 17M 14M 13M 17M 16M 17M 16M 12M 11M 19M 7M
totalNonCurrentAssets 81M 79M 83M 21M 21M 22M 22M 22M 23M 22M 18M 18M 26M 14M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 145M 135M 141M 74M 97M 104M 116M 93M 100M 104M 117M 119M 141M 79M
accountPayables 12M 10M 11M 3M 4M 3M 5M 3M 4M 5M 2M 2M 4M 4M
shortTermDebt 6M 5M 0 2M 15M 851 000 0 840 000 834 000 829 000 13M 10M 0 0
taxPayables 0 562 000 619 000 714 000 744 000 742 000 818 000 641 000 701 000 674 000 659 000 558 000 664 000 726 000
deferredRevenue 754 000 894 000 974 000 1M 1M 2M 2M 2M 2M 2M 2M 2M 3M 2M
otherCurrentLiabilities 11M 11M 9M 11M 8M 9M 8M 10M 8M 7M 11M 11M 5M 5M
totalCurrentLiabilities 29M 28M 31M 17M 29M 14M 20M 15M 15M 15M 33M 25M 16M 14M
longTermDebt 85M 75M 55M 48M 48M 59M 59M 39M 39M 39M 23M 30M 35M 35M
deferredRevenueNonCurrent 0 0 2000 0 15 000 35 000 200 000 354 000 513 000 671 000 829 000 981 000 1M 2M
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 37M 37M 0 0 0 0 0
otherNonCurrentLiabilities 0 0 0 4000 0 2M 0 -37M -37M 0 0 17M 0 0
totalNonCurrentLiabilities 85M 75M 78M 48M 48M 62M 62M 40M 40M 40M 27M 31M 40M 39M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 19M 25M 27M 3M 3M 2M 3M 3M 3M 4M 4M 4M 4M 4M
totalLiabilities 114M 103M 109M 65M 77M 76M 82M 55M 55M 55M 60M 56M 56M 53M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 685 000 661 000 557 000 303 000 301 000 300 000 291 000 289 000 288 000 285 000 273 000 270 000 264 000 191 000
retainedEarnings -452M -443M -420M -407M -394M -384M -376M -371M -361M -356M -346M -338M -309M -278M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 0 0 0 0 0 0 0 0
othertotalStockholdersEquity 478M 469M 416M 413M 411M 408M 407M 404M 400M
totalStockholdersEquity 27M 27M 28M 9M 19M 28M 34M 38M 45M 48M 57M 63M 85M 25M
totalEquity 31M 32M 32M 9M 19M 28M 34M 38M 45M 48M 57M 63M 85M 25M
totalLiabilitiesAndStockholdersEquity 145M 135M 74M 97M 104M 93M 100M 104M 119M
minorityInterest 4M 4M 4M 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 145M 135M 141M 74M 97M 104M 116M 93M 100M 104M 117M 119M 141M 79M
totalInvestments 490 000 279 000 292 000 712 000 4M 5M 2M 700 000 859 000 2M 3M 3M 4M 4M
totalDebt 91M 81M 83M 49M 63M 62M 62M 40M 40M 40M 40M 40M 40M 38M
netDebt 56M 63M 63M 28M 20M 15M 3M 4M -6M -15M -31M -34M -55M -11M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-27 2024-03-08 2023-03-07 2022-03-08 2021-03-02
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 24M 18M 14M 8M 7M
otherReceivables 0 0 0 0 0
prepaids 3M 3M 2M 2M 1M
totalPayables 12M 6M 3M 5M 4M
otherPayables 1M 818 000 659 000 664 000 726 000
accruedExpenses 4M 4M 3M 2M 2M
capitalLeaseObligationsCurrent 5M 845 000 824 000 670 000 594 000
capitalLeaseObligationsNonCurrent 23M 2M 3M 4M 3M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 447M 410M 403M 394M 303M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM STIM
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-04 2025-08-05 2024-11-12 2024-08-12 2024-05-07 2023-11-07 2023-08-08 2023-05-15 2022-11-08
acceptedDate 2025-11-04 07:31:53 2025-08-05 07:31:19 2025-03-27 16:36:09 2024-11-12 07:31:12 2024-08-12 07:30:58 2024-05-07 16:31:07 2024-03-07 21:44:57 2023-11-07 16:30:33 2023-08-08 16:31:51 2023-05-15 16:31:15 2023-03-07 16:39:58 2022-11-08 16:31:02 2022-03-08 16:31:12 2021-03-02 17:06:25
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -9M -10M -44M -13M -10M -8M -30M -9M -5M -11M -37M -8M -31M -27M
depreciationAndAmortization 886 000 901 000 2M 512 000 555 000 560 000 2M 499 000 488 000 516 000 2M 387 000 1M 941 000
deferredIncomeTax 0 0 0 0 0 0 0 3M -266 000 0 0 0 0 0
stockBasedCompensation 1M 2M 6M 1M 2M 1M 7M 2M 2M 2M 9M 2M 8M 4M
changeInWorkingCapital 6M 3M -7M 5M 2M -7M -14M -6M -13M -1M -5M -2M -7M -8M
accountsReceivables 4M 148 000 -4M -630 000 0 -3M -9M -2M -10M 4M -7M -572 000 -3M -597 000
inventory 551 000 -966 000 3M 874 000 516 000 1M -1M -3M 236 000 -243 000 -3M -1M -3M -945 000
accountsPayables 2M 835 000 -2M -680 000 1M -2M 2M -2M -907 000 2M -2M 57 000 276 000 -1M
otherWorkingCapital -422 000 3M -4M 6M 82 000 -4M -6M 970 000 -2M -7M 6M 338 000 -415 000 -6M
otherNonCashItems 322 000 778 000 12M 892 000 1M 7M 3M 138 000 134 000 188 000 1M 173 000 918 000 2M
netCashProvidedByOperatingActivities -785 000 -4M -31M -5M -5M -12M -32M -10M -15M -9M -31M -7M -28M -28M
investmentsInPropertyPlantAndEquipment -114 000 -252 000 -1M -386 000 -616 000 -375 000 -2M -552 000 -704 000 -234 000 -3M -726 000 -2M -730 000
acquisitionsNet 0 0 -3M 0 0 0 0 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 10000 0 0 620 000 0 234 000 0 0 0 535 000 0 0 324 000 0
otherInvestingActivites -10000 0 -220 000 497 000 443 000 618 000 6M -7M 10M
netCashUsedForInvestingActivites -114 000 -252 000 14 000 -119 000 68 000 66 000 6M -6M 9M
debtRepayment 10M 0 -16M 0 0 0 -62 000 -1M 0
commonStockIssued 8M 1000 0 0 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 0 -271 000 0 0 0 0 2M 0
netCashUsedProvidedByFinancingActivities 18M 1000 -16M 0 0 0 -62 000 499 000 0
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 -546 000 0 0 0 0 0
netChangeInCash 17M -4M -40M -22M -5M -12M -11M -10M -10M -15M -24M 3M 45M -27M
cashAtEndOfPeriod 34M 17M 19M 21M 43M 48M 60M 36M 46M 55M 70M 74M 94M 49M
cashAtBeginningOfPeriod 17M 21M 60M 43M 48M 60M 70M 46M 55M 70M 94M 71M 49M 76M
operatingCashFlow -785 000 -4M -31M -5M -5M -12M -32M -10M -15M -9M -31M -7M -28M -28M
capitalExpenditure -114 000 -252 000 -1M -386 000 -616 000 -375 000 -2M -552 000 -704 000 -234 000 -3M -726 000 -2M -730 000
freeCashFlow -899 000 -4M -32M -6M -6M -12M -34M -11M -16M -9M -34M -7M -30M -29M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-27 2024-03-08 2023-03-07 2022-03-08 2021-03-02
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 2M 1M 10M -8M 0
netCashProvidedByInvestingActivities -2M -1M 7M -10M -730 000
netDebtIssuance -3M 24M 0 0 3M
longTermNetDebtIssuance -3M 24M 0 0 3M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 0 0 81M 0
netCommonStockIssuance 0 0 0 81M 0
commonStockIssuance 0 0 0 81M 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -4M -1M 207 000 2M -131 000
netCashProvidedByFinancingActivities -7M 23M 207 000 83M 2M
incomeTaxesPaid 0 0 0 0 0
interestPaid 7M 5M 4M 0 4M

Earning call transcript

2025 q3
2025-11-04 ET (fiscal 2025 q3)
2025 q2
2025-08-05 ET (fiscal 2025 q2)
2025 q1
2025-05-06 ET (fiscal 2025 q1)
2024 q4
2025-03-04 ET (fiscal 2024 q4)
2024 q3
2024-11-12 ET (fiscal 2024 q3)
2024 q2
2024-08-12 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-03-05 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-13 ET (fiscal 2023 q1)
2022 q4
2023-03-07 ET (fiscal 2022 q4)
2022 q3
2022-11-11 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-05-12 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-04 07:31 ET
Neuronetics reported for 2025 q3
SEC form 8
2025-11-04 07:10 ET
Neuronetics published news for 2025 q3
SEC form 8
2025-11-04 07:10 ET
Neuronetics published news for 2025 q3
SEC form 8
2025-11-04 07:10 ET
Neuronetics published news for 2025 q3
SEC form 10
2025-08-05 11:31 ET
Neuronetics reported for 2025 q2
SEC form 10
2025-05-06 11:30 ET
Neuronetics reported for 2025 q1
SEC form 8
2025-05-06 11:10 ET
Neuronetics published news for 2025 q1
SEC form 8
2025-05-06 11:10 ET
Neuronetics published news for 2025 q1
SEC form 8
2025-05-06 11:10 ET
Neuronetics published news for 2025 q1
SEC form 10
2025-05-06 00:00 ET
Neuronetics published news for 2025 q1
SEC form 10
2025-03-27 20:36 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-03-27 20:35 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-03-27 20:35 ET
Neuronetics published news for 2024 q4
SEC form 10
2025-03-27 00:00 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-03-04 07:00 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-03-04 07:00 ET
Neuronetics reported for 2024 q4
SEC form 8
2025-03-04 07:00 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-02-07 23:12 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-02-07 23:12 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-02-07 23:12 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-02-07 23:12 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-02-07 23:12 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Neuronetics published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Neuronetics published news for 2024 q4
SEC form 8
2024-11-13 06:44 ET
Neuronetics published news for 2024 q3
SEC form 8
2024-11-13 06:44 ET
Neuronetics published news for 2024 q3
SEC form 10
2024-11-12 07:31 ET
Neuronetics reported for 2024 q3
SEC form 8
2024-11-12 07:01 ET
Neuronetics published news for 2024 q3
SEC form 8
2024-11-12 07:01 ET
Neuronetics published news for 2024 q3
SEC form 8
2024-11-12 07:01 ET
Neuronetics published news for 2024 q3
SEC form 10
2024-11-12 00:00 ET
Neuronetics published news for 2024 q3
SEC form 8
2024-08-12 17:10 ET
Neuronetics published news for 2024 q2
SEC form 8
2024-08-12 17:10 ET
Neuronetics published news for 2024 q2
SEC form 8
2024-08-12 08:32 ET
Neuronetics published news for 2024 q2
SEC form 8
2024-08-12 08:32 ET
Neuronetics published news for 2024 q2
SEC form 8
2024-08-12 08:32 ET
Neuronetics published news for 2024 q2
SEC form 10
2024-08-12 07:30 ET
Neuronetics reported for 2024 q2
SEC form 10
2024-08-12 00:00 ET
Neuronetics published news for 2024 q2
SEC form 10
2024-05-07 16:31 ET
Neuronetics published news for 2024 q1
SEC form 8
2024-05-07 07:31 ET
Neuronetics published news for 2024 q1
SEC form 8
2024-05-07 07:31 ET
Neuronetics reported for 2024 q1
SEC form 10
2024-05-07 00:00 ET
Neuronetics published news for 2024 q1
SEC form 10
2024-03-08 00:00 ET
Neuronetics published news for 2023 q4
SEC form 10
2024-03-07 21:44 ET
Neuronetics published news for 2023 q4
SEC form 8
2024-03-05 07:31 ET
Neuronetics published news for 2023 q4
SEC form 8
2024-03-05 07:31 ET
Neuronetics reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Neuronetics published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Neuronetics published news for 2023 q4
SEC form 10
2023-11-07 16:30 ET
Neuronetics published news for 2023 q3
SEC form 8
2023-11-07 07:31 ET
Neuronetics reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Neuronetics published news for 2023 q3
SEC form 10
2023-08-08 16:31 ET
Neuronetics published news for 2023 q2
SEC form 6
2023-08-08 07:31 ET
Neuronetics reported for 2023 q2
SEC form 6
2023-08-08 07:30 ET
Neuronetics published news for 2023 q2
SEC form 10
2023-08-08 00:00 ET
Neuronetics published news for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Neuronetics published news for 2023 q2
SEC form 10
2023-05-15 00:00 ET
Neuronetics published news for 2023 q1
SEC form 8
2023-05-09 00:00 ET
Neuronetics published news for 2023 q1
SEC form 6
2023-04-04 09:25 ET
Neuronetics published news for 2023 q1
SEC form 6
2023-03-10 17:28 ET
Neuronetics published news for 2022 q4
SEC form 10
2023-03-07 16:39 ET
Neuronetics reported for 2022 q4
SEC form 6
2023-03-07 07:31 ET
Neuronetics published news for 2022 q4
SEC form 6
2023-03-07 07:30 ET
Neuronetics published news for 2022 q4
SEC form 10
2023-03-07 00:00 ET
Neuronetics reported for 2022 q4
SEC form 8
2023-03-07 00:00 ET
Neuronetics reported for 2022 q4
SEC form 6
2023-02-27 16:16 ET
Neuronetics published news for 2022 q4
SEC form 6
2023-01-09 16:07 ET
Neuronetics published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Neuronetics published news for 2022 q4
SEC form 6
2022-12-29 16:15 ET
Neuronetics published news for 2022 q3
SEC form 10
2022-11-08 16:31 ET
Neuronetics reported for 2022 q3
SEC form 6
2022-11-08 07:32 ET
Neuronetics published news for 2022 q3
SEC form 6
2022-11-08 07:31 ET
Neuronetics published news for 2022 q3
SEC form 10
2022-11-08 00:00 ET
Neuronetics reported for 2022 q3
SEC form 8
2022-11-08 00:00 ET
Neuronetics reported for 2022 q3
SEC form 6
2022-08-26 16:30 ET
Neuronetics published news for 2022 q2
SEC form 10
2022-08-02 16:31 ET
Neuronetics reported for 2022 q2
SEC form 6
2022-08-02 07:32 ET
Neuronetics published news for 2022 q2
SEC form 6
2022-08-02 07:30 ET
Neuronetics published news for 2022 q2
SEC form 10
2022-08-02 00:00 ET
Neuronetics reported for 2022 q2
SEC form 8
2022-08-02 00:00 ET
Neuronetics reported for 2022 q2
SEC form 6
2022-07-18 16:30 ET
Neuronetics published news for 2022 q2
SEC form 6
2022-05-27 16:30 ET
Neuronetics published news for 2022 q1
SEC form 10
2022-05-12 16:33 ET
Neuronetics reported for 2022 q1
SEC form 6
2022-05-12 07:32 ET
Neuronetics published news for 2022 q1
SEC form 6
2022-05-12 07:30 ET
Neuronetics published news for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Neuronetics reported for 2022 q1
SEC form 8
2022-05-12 00:00 ET
Neuronetics reported for 2022 q1
SEC form 6
2022-05-05 16:30 ET
Neuronetics published news for 2022 q1
SEC form 6
2022-04-14 16:16 ET
Neuronetics published news for 2022 q1
SEC form 10
2022-03-08 16:31 ET
Neuronetics published news for 2021 q4
SEC form 6
2022-03-08 07:32 ET
Neuronetics published news for 2021 q4
SEC form 6
2022-03-08 07:30 ET
Neuronetics published news for 2021 q4
SEC form 10
2022-03-08 00:00 ET
Neuronetics published news for 2021 q4
SEC form 8
2022-03-08 00:00 ET
Neuronetics published news for 2021 q4
SEC form 6
2022-02-28 16:30 ET
Neuronetics published news for 2021 q4
SEC form 6
2022-02-22 07:30 ET
Neuronetics published news for 2021 q4
SEC form 6
2022-01-10 08:30 ET
Neuronetics published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Neuronetics published news for 2021 q4
SEC form 10
2021-11-09 16:31 ET
Neuronetics published news for 2021 q3
SEC form 6
2021-11-09 07:33 ET
Neuronetics published news for 2021 q3
SEC form 6
2021-11-09 07:30 ET
Neuronetics published news for 2021 q3
SEC form 10
2021-11-09 00:00 ET
Neuronetics published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Neuronetics published news for 2021 q3
SEC form 6
2021-10-19 20:17 ET
Neuronetics published news for 2021 q3
SEC form 6
2021-10-12 17:28 ET
Neuronetics published news for 2021 q3
SEC form 8
2021-10-12 00:00 ET
Neuronetics published news for 2021 q3
SEC form 6
2021-10-05 16:29 ET
Neuronetics published news for 2021 q3
SEC form 6
2021-08-05 21:02 ET
Neuronetics published news for 2021 q2
SEC form 10
2021-08-03 16:32 ET
Neuronetics published news for 2021 q2
SEC form 6
2021-08-03 14:55 ET
Neuronetics published news for 2021 q2
SEC form 6
2021-08-03 07:33 ET
Neuronetics published news for 2021 q2
SEC form 6
2021-08-03 07:30 ET
Neuronetics published news for 2021 q2
SEC form 10
2021-08-03 00:00 ET
Neuronetics published news for 2021 q2
SEC form 8
2021-08-03 00:00 ET
Neuronetics published news for 2021 q2
SEC form 6
2021-07-02 16:46 ET
Neuronetics published news for 2021 q2
SEC form 6
2021-06-01 19:51 ET
Neuronetics published news for 2021 q1
SEC form 10
2021-05-04 16:32 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-05-04 07:37 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-05-04 07:30 ET
Neuronetics published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
Neuronetics published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-04-14 17:20 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-04-14 16:06 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-04-09 17:00 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-04-05 16:32 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-04-01 16:57 ET
Neuronetics published news for 2021 q1
SEC form 6
2021-03-11 17:15 ET
Neuronetics published news for 2020 q4
SEC form 10
2021-03-02 17:06 ET
Neuronetics published news for 2020 q4
SEC form 6
2021-03-02 07:31 ET
Neuronetics published news for 2020 q4
SEC form 6
2021-03-02 07:30 ET
Neuronetics published news for 2020 q4
SEC form 6
2021-02-02 16:10 ET
Neuronetics published news for 2020 q4
SEC form 6
2021-01-28 16:52 ET
Neuronetics published news for 2020 q4
SEC form 6
2021-01-13 08:01 ET
Neuronetics published news for 2020 q4
SEC form 6
2020-12-08 16:26 ET
Neuronetics published news for 2020 q3
SEC form 10
2020-11-02 17:00 ET
Neuronetics published news for 2020 q3
SEC form 6
2020-11-02 16:11 ET
Neuronetics published news for 2020 q3
SEC form 6
2020-11-02 16:10 ET
Neuronetics published news for 2020 q3